How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Hosted on MSN
Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock
Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The new site will double the company’s capacity to sort mixed alloy scrap using its AI-driven sorting technology.
Richard Socher's new $650 million startup wants to build an AI that can research and improve itself indefinitely — and he ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
A merge sort uses smaller, ordered lists which are easier to sort and merge than larger lists. It is usually more efficient and quicker than the bubble sort. It is more complex to code. It will still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results